Neuroene Therapeutics awarded $1.5 million to develop anti-seizure compound for epilepsy
(Medical University of South Carolina) Neuroene Therapeutics LLC, a start-up company founded by Medical University of South Carolina researchers, will optimize vitamin K analogues that have shown promise for improving seizure control in preclinical models of drug-resistant epilepsy with funding from a $1.5 million NIH Phase II Small Business Innovation Research grant. The vitamin K analogues improve seizure control by supporting mitochondrial health in brain cells. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 29, 2018 Category: International Medicine & Public Health Source Type: news

12.10.18: Not intended for U.S. and UK Media
U.S. FDA approves Bayer's Xarelto® for patients with coronary or peripheral artery diseaseXarelto, in combination with aspirin, is indicated to reduce the risk of major cardiovascular events in patients with chronic coronary artery disease or peripheral artery disease / Xarelto, in combination with aspirin, is the only non-vitamin K antagonist oral anticoagulant (NOAC) indicated for this patient group / Approval in the U.S. follows regulatory clearance in both Europe and Canadamehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - October 12, 2018 Category: Pharmaceuticals Source Type: news

U.S. FDA approves Bayer & #8217;s Xarelto ® for patients with coronary or peripheral artery disease (for specialized target groups only)
Xarelto, in combination with aspirin, is indicated to reduce the risk of major cardiovascular events in patients with chronic coronary artery disease or peripheral artery disease / Xarelto, in combination with aspirin, is the only non-vitamin K antagonist oral anticoagulant (NOAC) indicated for this patient group / Approval in the U.S. follows regulatory clearance in both Europe and Canada (Source: Bayer Company News)
Source: Bayer Company News - October 12, 2018 Category: Pharmaceuticals Source Type: news

Vitamin K2 Steps Into the Spotlight for Bone and Heart Health Vitamin K2 Steps Into the Spotlight for Bone and Heart Health
When it comes to osteoporosis and cardiovascular disease, this unassuming variant of vitamin K may have a lot to offer.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 10, 2018 Category: Consumer Health News Tags: Public Health & Prevention Article Source Type: news

Anticoagulation for people with cancer and central venous catheters
This review found moderate-certainty evidence that LMWH reduces catheter ‐related venous thromboembolism (CR-VTE); evidence was inconclusive for LMWH effects on mortality and effects of vitamin K antagonists (VKA) on mortality or CR-VTE, and for LMWH versus VKA. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 28, 2018 Category: Consumer Health News Source Type: news

Why Whole-Fat Milk and Yogurt Are Healthier Than You Think
For years, experts have recommended low-fat dairy products over the full-fat versions, which are higher in calories and contain more saturated fat. Recent research, however, indicates that full-fat dairy may actually be healthier than its reputation suggests, and that people who eat full-fat dairy are not more likely to develop cardiovascular disease and type 2 diabetes than people who consume low-fat dairy. They may even be less likely to gain weight. Now, new research published Tuesday in The Lancet, adds to that body of evidence. The research suggests that eating dairy products of all kinds is associated with a lower ri...
Source: TIME: Health - September 11, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Diet/Nutrition healthytime Source Type: news

Children and teens who supplement with vitamin K have a reduced risk of fractures
(Natural News) Researchers have discovered a new approach to make the bones of children and teenagers stronger. A pilot study from Poland, the U.S., and the Netherlands, which was published in the journal Nutrients, revealed that children and teenagers who consume more vitamin K were less likely to experience bone fractures. In the study, the... (Source: NaturalNews.com)
Source: NaturalNews.com - September 5, 2018 Category: Consumer Health News Source Type: news

24.08.18: Not intended for U.S. and UK Media
Bayer secures approval in the EU for Xarelto® (rivaroxaban) for patients with coronary or peripheral artery diseaseXarelto is the only non-vitamin K antagonist oral anticoagulant (NOAC) indicated in combination with acetylsalicylic acid (ASA) for the prevention of atherothrombotic events in patients with coronary artery disease or symptomatic peripheral artery disease at high risk for ischemic events / Launch first expected in Germanymehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 24, 2018 Category: Pharmaceuticals Source Type: news

Bayer secures approval in the EU for Xarelto ® (rivaroxaban) for patients with coronary or peripheral artery disease (for specialized target groups only)
Xarelto is the only non-vitamin K antagonist oral anticoagulant (NOAC) indicated in combination with acetylsalicylic acid (ASA) for the prevention of atherothrombotic events in patients with coronary artery disease or symptomatic peripheral artery disease at high risk for ischemic events / Launch first expected in Germany (Source: Bayer Company News)
Source: Bayer Company News - August 24, 2018 Category: Pharmaceuticals Source Type: news

Is Guacamole Healthy? Here ’s What the Experts Say
Guacamole has a solid reputation as a crowdpleaser, for sports fans and health nuts alike. Even the Aztecs indulged in ahuaca-mulli, or avocado sauce. But is guacamole good for you? Here’s what the experts say. What’s in guacamole? Guacamole’s main ingredient is avocado, a creamy green fruit full of heart-healthy, easy-to-digest monounsaturated fats. It’s typically mixed with salt and lime juice. Some recipes also call for onion, cilantro, tomato, garlic and spices like cayenne pepper or cumin. “It’s easy to spice up your guacamole by adding in jalapeños, chili peppers and hot sau...
Source: TIME: Health - August 22, 2018 Category: Consumer Health News Authors: Cassie Shortsleeve  Tags: Uncategorized Diet/Nutrition healthytime Source Type: news

Did you know that you have E.coli in your body right now? Some strains are actually needed for your survival
(Natural News) In the U.S., most food poisoning cases are caused by E. coli outbreaks. Still, it’s important to know that while some strains of E. coli are indeed harmful to humans, not all types are pathogenic. You even have different strains of E. coli in your intestines, such as a strain of the bacteria that can produce the vitamin K that... (Source: NaturalNews.com)
Source: NaturalNews.com - August 14, 2018 Category: Consumer Health News Source Type: news

WATCH: Celery juice is the latest wellness trend: Is it one you should follow?
Celery provides fiber and vitamin K, but experts say drinking celery is no more nutritious than eating it raw. (Source: ABC News: Health)
Source: ABC News: Health - August 14, 2018 Category: Consumer Health News Tags: GMA Source Type: news

27.07.18: Not intended for U.S. and UK Media
Bayer receives positive CHMP opinion for rivaroxaban for patients with coronary or peripheral artery diseasePositive CHMP opinion based on data from the largest Phase III rivaroxaban study, COMPASS / Once approved, rivaroxaban will be the only non-vitamin K antagonist oral anticoagulant (NOAC) indicated in combination with acetylsalicylic acid (ASA) for the prevention of atherothrombotic events in adult patients with coronary artery disease (CAD) or symptomatic peripheral artery disease (PAD) at high risk for ischaemic eventsmehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - July 27, 2018 Category: Pharmaceuticals Source Type: news

Bayer receives positive CHMP opinion for rivaroxaban for patients with coronary or peripheral artery disease (for specialized target groups only)
Positive CHMP opinion based on data from the largest Phase III rivaroxaban study, COMPASS / Once approved, rivaroxaban will be the only non-vitamin K antagonist oral anticoagulant (NOAC) indicated in combination with acetylsalicylic acid (ASA) for the prevention of atherothrombotic events in adult patients with coronary artery disease (CAD) or symptomatic peripheral artery disease (PAD) at high risk for ischaemic events (Source: Bayer Company News)
Source: Bayer Company News - July 27, 2018 Category: Pharmaceuticals Source Type: news

Parental Refusal to Give IM Vitamin K May Put Newborns at Risk Parental Refusal to Give IM Vitamin K May Put Newborns at Risk
Refusal of intramuscular (IM) vitamin K administration by parents of newborns is an emerging problem in the U.S., and interventions to minimize risks to these newborns are needed, researchers say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 23, 2018 Category: Consumer Health News Tags: Pediatrics News Source Type: news

This Infant Disease Was Eradicated. Now It's Back. Why?
(MedPage Today) -- Some parents are refusing routine vitamin K shots for their newborns, as F. Perry Wilson, MD, explains (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - July 20, 2018 Category: Pediatrics Source Type: news

Ten Commandments of the EHRA Guide for Use of NOACs in AF Ten Commandments of the EHRA Guide for Use of NOACs in AF
Review the 10 most important take-aways from the 2018 EHRA NOAC Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with AF.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 14, 2018 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Vitamin K: The anti-aging supplement you probably haven’t heard about
(Natural News) Whether we like it or not, all of us get older. Yet there are people who don’t look their biological age, causing some of us to mutter and wonder why these people should be so lucky. “It’s just not fair,” we say, wondering why our face is filled with wrinkles and crow’s feet.... (Source: NaturalNews.com)
Source: NaturalNews.com - June 13, 2018 Category: Consumer Health News Source Type: news

Notes from the Field: Outbreak of Severe Illness Linked to the Vitamin K Antagonist Brodifacoum and Use of Synthetic Cannabinoids — Illinois, March–April 2018
(Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - May 31, 2018 Category: American Health Source Type: news

Outbreak of Life-threatening Coagulopathy Associated with Synthetic Cannabinoids Use
The CDC is providing information on: 1) the current status of a multistate outbreak of coagulopathy from exposure to synthetic cannabinoid products containing a vitamin K-dependent antagonist agent; 2) signs and symptoms of presenting patients from this outbreak and which patients are at risk; 3) laboratory testing options that are available to help identify and classify cases; 4) available resources that may help clinicians make decisions; and 5) to whom to report possible cases. (Source: PHPartners.org)
Source: PHPartners.org - May 25, 2018 Category: International Medicine & Public Health Source Type: news

Protective protein activated by vitamin K found, inactive, abundant in blacks on dialysis
(Medical College of Georgia at Augusta University) High levels of a protein activated by vitamin K and associated with cardiovascular disease when it isn't, has been found in the blood of African-Americans on dialysis, investigators report. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 15, 2018 Category: International Medicine & Public Health Source Type: news

Impact of NOACs on Ischemic Stroke Severity in AF Impact of NOACs on Ischemic Stroke Severity in AF
Can the use of non-vitamin K-dependent oral anticoagulants prior to stroke onset in patients with atrial fibrillation reduce the severity of stroke, if ischemic stroke should occur?Europace (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 11, 2018 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Novel Oral Anticoagulants in CKD: Ready for Prime Time? Novel Oral Anticoagulants in CKD: Ready for Prime Time?
Are novel oral anticoagulants a safe and effective alternative to vitamin K antagonists in patients with chronic kidney disease?Current Opinion in Nephrology and Hypertension (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 7, 2018 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

Five Things Surgeons Need to Know About NOACs to Minimize Risks Five Things Surgeons Need to Know About NOACs to Minimize Risks
Non-vitamin K oral anticoagulants (NOACs) differ in important ways from warfarin, and surgeons need to appreciate these differences, researchers say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 27, 2018 Category: Consumer Health News Tags: General Surgery News Source Type: news

Medical News Today: Best 40 foods for vitamin K
Vitamin K is an essential nutrient that helps the body clot blood, build strong bones, and keep the heart healthy. In this article, we look at foods to eat to increase vitamin K intake, including kale, spinach, other leafy greens, some dairy products, and natto. Learn about the difference between vitamin K-1 and K-2. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 23, 2018 Category: Consumer Health News Tags: Nutrition / Diet Source Type: news

Fake Marijuana Likely Laced With Rat Poison Has Killed 3 People and Sickened More Than 100
Fake marijuana likely contaminated with rat poison has killed three people in Illinois and caused severe bleeding in more than 100 others, including a few in four other states. The federal Centers for Disease Control and Prevention has alerted doctors nationwide that patients with severe, unexplained bleeding may be additional cases. The CDC is helping Illinois authorities investigate the outbreak in that state, which began in early March. Illinois reported seven more cases on Tuesday, bringing the nationwide total to at least 116. Several patients and samples of so-called synthetic marijuana from Illinois have tested posi...
Source: TIME: Health - April 11, 2018 Category: Consumer Health News Authors: Lindsey Tanner / AP Tags: Uncategorized Marijuana onetime Source Type: news

Synthetic Cannabis Laced With Poison Linked to Severe Bleeding Synthetic Cannabis Laced With Poison Linked to Severe Bleeding
Federal health officials warn of an outbreak of potentially life-threatening vitamin K-dependent antagonist coagulopathy after use of synthetic cannabinoids.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 6, 2018 Category: Consumer Health News Tags: Psychiatry News Alert Source Type: news

New EHRA Practical Guide on non-vitamin K antagonist oral anticoagulants launched
(European Society of Cardiology) A new version of the EHRA Practical Guide on the use of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation is published online today in European Heart Journal and an executive summary in EP Europace, and presented at EHRA 2018, a European Society of Cardiology (ESC) congress.1-3 The guide, now in its third edition with more than 400,000 copies of previous versions distributed worldwide, was produced by the European Heart Rhythm Association (EHRA), a branch of the ESC. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - March 19, 2018 Category: International Medicine & Public Health Source Type: news

Why vitamin K is the anti-ageing supplement you need
Nutritional director Rick Hay describes the vitamin that often goes unmentioned: vitamin K. He suggests taking vitamin K2 could help reduce bone loss and cardiovascular health (Source: the Mail online | Health)
Source: the Mail online | Health - March 7, 2018 Category: Consumer Health News Source Type: news

Rat poisoning: a challenging diagnosis with clinical and psychological implications - Simmons SC, Taylor LJ, Marques MB, Williams LA.
Rat poisoning should be considered in the differential diagnosis of a patient presenting with signs and symptoms of vitamin K deficiency without a more likely explanation. However, confirming this diagnosis may be difficult due to the varying sensitivities... (Source: SafetyLit)
Source: SafetyLit - January 29, 2018 Category: International Medicine & Public Health Tags: Home and Consumer Product Safety Source Type: news

Medical News Today: Vitamin K deficiency: What you need to know
The main symptom of a vitamin K deficiency is excessive bleeding caused by an inability to form blood clots. Learn about vitamin K in adults and infants. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 23, 2017 Category: Consumer Health News Tags: Nutrition / Diet Source Type: news

GI Bleeding With Non-Vitamin K Antagonist Oral Anticoagulants GI Bleeding With Non-Vitamin K Antagonist Oral Anticoagulants
This meta-analysis assessed the risk of GI bleeding associated with non-vitamin K antagonist oral anticoagulants as compared with conventional anticoagulation therapy.Clinical Gastroenterology and Hepatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 11, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Cardiology Experts Offer Guidance on Managing Bleeding Events in Patients on Oral Anticoagulants
The American College of Cardiology has published a guide to managing acute bleeding in patients taking direct oral anticoagulants and vitamin K antagonists. The decision... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - December 4, 2017 Category: Primary Care Source Type: news

Bayer submits application for marketing approval of rivaroxaban for patients with coronary or peripheral artery disease to European Medicines Agency (for specialized target groups only)
The rivaroxaban vascular dose, 2.5 mg twice daily plus aspirin 100 mg once daily, demonstrated a 24% reduction in the combined risk of stroke, cardiovascular death and heart attack / The application for marketing approval is based on the COMPASS study / If approved, the rivaroxaban vascular dose, 2.5 mg twice daily plus aspirin low dose once daily, will be the only non-vitamin K antagonist oral anticoagulant (NOAC) indicated for this patient population (Source: Bayer Company News)
Source: Bayer Company News - November 6, 2017 Category: Pharmaceuticals Source Type: news

06.11.17: Not intended for U.S. and UK Media
Bayer submits application for marketing approval of rivaroxaban for patients with coronary or peripheral artery disease to European Medicines AgencyThe rivaroxaban vascular dose, 2.5 mg twice daily plus aspirin 100 mg once daily, demonstrated a 24% reduction in the combined risk of stroke, cardiovascular death and heart attack (1) / The application for marketing approval is based on the COMPASS study / If approved, the rivaroxaban vascular dose, 2.5 mg twice daily plus aspirin low dose once daily, will be the only non-vitamin K antagonist oral anticoagulant (NOAC) indicated for this patient populationmehr ... (Source: Baye...
Source: Bayer IR Newsfeed: Events - November 5, 2017 Category: Pharmaceuticals Source Type: news

Combined Adequate Vitamin K and D Could Improve Knee OA (CME/CE)
(MedPage Today) -- Post-hoc analysis of trial data suggests benefit (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - October 27, 2017 Category: Geriatrics Source Type: news

Zoo cure heals humans
One of the highlights of my trip to Tanzania in 2012 was visiting the Ngorongoro Crater and Conservation Area. They have the largest lions on the planet. I got very close as part of my invitation by the director of park services. Along with elephants, lions, gazelles and zebras, I got to see wildebeest, the almost-extinct black rhino and giraffes. I was lucky enough to photograph this giraffe on my trip to Ngorongoro Crater in Tanzania. I am always awed when I see these magnificent creatures in their native environment. They thrive the same way they did thousands of years ago. But when these animals are tak...
Source: Al Sears, MD Natural Remedies - October 19, 2017 Category: Complementary Medicine Authors: Cathy Card Tags: Anti-Aging Source Type: news

Vitamin K essential to a healthy heart; deficiency found to contribute to unhealthy enlargement in adolescents
(Natural News) Eating more foods rich in vitamin K makes the heart healthier, according to a recent study reported by Science Daily. Researchers from the Medical College of Georgia (MCG) at Augusta University (AU) studied 766 healthy teenagers aged 14 to 18. They asked the subjects to wear activity monitors for seven days and to self-document... (Source: NaturalNews.com)
Source: NaturalNews.com - October 19, 2017 Category: Consumer Health News Source Type: news

Vitamin K in kale and broccoli keeps hearts healthy
Researchers from Augusta University found vitamin K maintains the size of the heart's left ventricle, which is the largest of the organ's four chambers and is responsible for pumping out oxygen-rich blood. (Source: the Mail online | Health)
Source: the Mail online | Health - October 6, 2017 Category: Consumer Health News Source Type: news

Medical News Today: Leafy greens may contribute to a healthy heart
In a first-of-its-kind study, researchers examine the link between vitamin K and the structure and good functioning of the heart in teenagers. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 6, 2017 Category: Consumer Health News Tags: Nutrition / Diet Source Type: news

Too Little Vitamin K Could Harm Young Hearts
WEDNESDAY, Oct. 4, 2017 -- Bypassing leafy green veggies could take a toll on teens'heart health, new research suggests. Teens who ate the least vitamin K-rich foods -- such as spinach, cabbage, iceberg lettuce and olive oil -- had triple the risk... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 4, 2017 Category: General Medicine Source Type: news

Non-Vitamin-K Oral Anticoagulants Linked to Major Bleeds via Drug Interactions (FREE)
By Joe Elia Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM Non-vitamin-K oral anticoagulants (NOACs) are associated with major bleeding episodes caused by drug-drug interactions, a Taiwanese study finds. The authors note … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - October 4, 2017 Category: Primary Care Source Type: news

Scientists have found another reason for children to eat their green leafy vegetables
(Medical College of Georgia at Augusta University) A study of 766 otherwise healthy adolescents showed that those who consumed the least vitamin K1-- found in spinach, cabbage, iceberg lettuce and olive oil -- were at 3.3 times greater risk for an unhealthy enlargement of the major pumping chamber of their heart, according to the study published in The Journal of Nutrition. Vitamin K1, or phylloquinone, is the predominant form of vitamin K in the U.S. diet. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - October 2, 2017 Category: Biology Source Type: news

CYP2C9 Variants Linked to Clinical Events in VTE
Risk of any clinical event, death, non - major bleeding up for seniors treated with vitamin K antagonists (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 5, 2017 Category: Cancer & Oncology Tags: Internal Medicine, Emergency Medicine, Oncology, Pathology, Pharmacy, Pulmonology, Geriatrics, Journal, Source Type: news

Reversal Strategies for Non-vitamin K Antagonist OACs Reversal Strategies for Non-vitamin K Antagonist OACs
What are the current best options for the reversal of the effects of NOACs due to an emergency situation?European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 11, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Stroke warning: Taking THIS vitamin could put you at risk of a blood clot
STROKES can occur when a blood clot blocks the flow of blood through a blood vessel. Those at risk are usually prescribed anticoagulants - however taking vitamin K can interfere with how well they work. (Source: Daily Express - Health)
Source: Daily Express - Health - August 9, 2017 Category: Consumer Health News Source Type: news

Bayer ’s Xarelto in Combination with Single Antiplatelet Therapy Receives Positive CHMP Opinion for Treatment of Patients with Atrial Fibrillation requiring oral Anticoagulation and undergoing Percutaneous Coronary Intervention with Stent Placement (for specialized target groups only)
Positive CHMP Opinion is based on data from the Phase IIIb PIONEER AF-PCI study, which demonstrated significantly reduced rates of clinically significant bleeding with Xarelto compared with VKA in patients with non-valvular atrial fibrillation (AF) who require oral anticoagulation and are also receiving antiplatelet therapy after percutaneous coronary intervention (PCI) with stent placement (1) / PIONEER AF-PCI is the first and currently only randomised clinical trial of a non-vitamin K antagonist oral anticoagulant (NOAC) in this patient population / Final decision of European Commission expected by the end of this year (...
Source: Bayer Company News - July 21, 2017 Category: Pharmaceuticals Source Type: news

21.07.17: Not intended for U.S. and UK Media
Bayer's Xarelto in Combination with Single Antiplatelet Therapy Receives Positive CHMP Opinion for Treatment of Patients with Atrial Fibrillation requiring oral Anticoagulation and undergoing Percutaneous Coronary Intervention with Stent PlacementPositive CHMP Opinion is based on data from the Phase IIIb PIONEER AF-PCI study, which demonstrated significantly reduced rates of clinically significant bleeding with Xarelto compared with VKA in patients with non-valvular atrial fibrillation (AF) who require oral anticoagulation and are also receiving antiplatelet therapy after percutaneous coronary intervention (PCI) with stent...
Source: Bayer IR Newsfeed: Events - July 20, 2017 Category: Pharmaceuticals Source Type: news